TMPPF yields 4000.00% · PFE yields 6.13%● Live data
📍 TMPPF pulled ahead of the other in Year 1
Combined, TMPPF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TMPPF + PFE for your $10,000?
Times China Holdings Limited, an investment holding company, operates as a property developer in the People's Republic of China. The company operates through Property Development, Urban Redevelopment Business, and Property Leasing segments. The Property Development segment develops and sells residential and commercial properties. The Urban Redevelopment Business segment is involved in the sale of land held for development and other related activities. The Property Leasing segment engages in the development, leasing, and sub-leasing of commercial properties owned by the company or independent third parties. The company also provides money lending and consulting management services. As of 31 December 2021, it had total land reserves of approximately 19.9 million sq.m. The company was formerly known as Times Property (Holdings) Co., Limited and changed its name to Times China Holdings Limited in February 2018. Times China Holdings Limited was founded in 1999 and is headquartered in Guangzhou, the People's Republic of China.
Full TMPPF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.